Chicago Partners Investment Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.6M | Sell |
18,216
-3,758
| -17% | -$3.84M | 0.43% | 50 |
|
|
2026
Q1 | $20.2M | Buy |
21,974
+570
| +3% | +$578K | 0.45% | 50 |
|
|
2025
Q4 | $22.8M | Buy |
21,404
+162
| +0.8% | +$155K | 0.56% | 40 |
|
|
2025
Q3 | $17.4M | Sell |
21,242
-80
| -0.4% | -$59.5K | 0.46% | 51 |
|
|
2025
Q2 | $17M | Buy |
21,322
+111
| +0.5% | +$86.3K | 0.49% | 45 |
|
|
2025
Q1 | $16.5M | Buy |
21,211
+2,314
| +12% | +$1.93M | 0.55% | 42 |
|
|
2024
Q4 | $14.9M | Buy |
18,897
+369
| +2% | +$306K | 0.49% | 46 |
|
|
2024
Q3 | $16.7M | Sell |
18,528
-216
| -1% | -$194K | 0.6% | 39 |
|
|
2024
Q2 | $14.8M | Sell |
18,744
-160
| -0.8% | -$128K | 0.57% | 40 |
|
|
2024
Q1 | $14.1M | Sell |
18,904
-527
| -3% | -$375K | 0.6% | 37 |
|
|
2023
Q4 | $12.3M | Sell |
19,431
-1,502
| -7% | -$877K | 0.57% | 40 |
|
|
2023
Q3 | $12.1M | Sell |
20,933
-491
| -2% | -$253K | 0.65% | 32 |
|
|
2023
Q2 | $9.74M | Buy |
21,424
+1,867
| +10% | +$783K | 0.51% | 43 |
|
|
2023
Q1 | $7.5M | Buy |
19,557
+11,091
| +131% | +$3.74M | 0.44% | 53 |
|
|
2022
Q4 | $2.88M | Buy |
8,466
+931
| +12% | +$330K | 0.18% | 122 |
|
|
2022
Q3 | $2.75M | Buy |
7,535
+71
| +1% | +$22.5K | 0.2% | 114 |
|
|
2022
Q2 | $2.46M | Sell |
7,464
-2,388
| -24% | -$717K | 0.18% | 112 |
|
|
2022
Q1 | $2.91M | Buy |
9,852
+5,043
| +105% | +$1.3M | 0.22% | 95 |
|
|
2021
Q4 | $1.13M | Buy |
4,809
+57
| +1% | +$14.4K | 0.08% | 202 |
|
|
2021
Q3 | $1.25M | Buy |
4,752
+83
| +2% | +$20.5K | 0.09% | 194 |
|
|
2021
Q2 | $1.14M | Sell |
4,669
-1,057
| -18% | -$212K | 0.08% | 192 |
|
|
2021
Q1 | $1.07M | Buy |
5,726
+1,627
| +40% | +$318K | 0.09% | 192 |
|
|
2020
Q4 | $845K | Buy |
4,099
+168
| +4% | +$25.1K | 0.08% | 197 |
|
|
2020
Q3 | $515K | Sell |
3,931
-196
| -5% | -$30.3K | 0.06% | 230 |
|
|
2020
Q2 | $662K | Sell |
4,127
-33
| -0.8% | -$5.07K | 0.08% | 182 |
|
|
2020
Q1 | $654K | Buy |
4,160
+833
| +25% | +$114K | 0.1% | 157 |
|
|
2019
Q4 | $471K | Buy |
3,327
+287
| +9% | +$33.3K | 0.06% | 223 |
|
|
2019
Q3 | $328K | Sell |
3,040
-5
| -0.2% | -$557 | 0.05% | 248 |
|
|
2019
Q2 | $327K | Buy |
3,045
+66
| +2% | +$7.77K | 0.05% | 243 |
|
|
2019
Q1 | $343K | Sell |
2,979
-1,334
| -31% | -$162K | 0.05% | 224 |
|
|
2018
Q4 | $500K | Sell |
4,313
-589
| -12% | -$65.8K | 0.07% | 184 |
|
|
2018
Q3 | $527K | Buy |
4,902
+591
| +14% | +$59.1K | 0.08% | 179 |
|
|
2018
Q2 | $368K | Buy |
4,311
+2
| +0% | +$164 | 0.06% | 211 |
|
|
2018
Q1 | $333K | Buy |
4,309
+1
| +0% | +$81 | 0.06% | 202 |
|
|
2017
Q4 | $364K | Sell |
4,308
-68
| -2% | -$5.79K | 0.06% | 197 |
|
|
2017
Q3 | $374K | Buy |
4,376
+551
| +14% | +$45.2K | 0.06% | 190 |
|
|
2017
Q2 | $299K | Buy |
3,825
+1,525
| +66% | +$124K | 0.08% | 148 |
|
|
2017
Q1 | $193K | Sell |
2,300
-44
| -2% | -$3.52K | 0.05% | 192 |
|
|
2016
Q4 | $172K | Buy |
2,344
+44
| +2% | +$3.28K | 0.06% | 185 |
|
|
2016
Q3 | $185K | Hold |
2,300
| – | – | 0.07% | 178 |
|
|
2016
Q2 | $181K | Hold |
2,300
| – | – | 0.09% | 141 |
|
|
2016
Q1 | $166K | Hold |
2,300
| – | – | 0.09% | 145 |
|
|
2015
Q4 | $194K | Hold |
2,300
| – | – | 0.09% | 156 |
|
|
2015
Q3 | $192K | Hold |
2,300
| – | – | 0.11% | 133 |
|
|
2015
Q2 | $192K | Sell |
2,300
-122
| -5% | -$9.3K | 0.09% | 138 |
|
|
2015
Q1 | $167K | Buy |
2,422
+122
| +5% | +$8.69K | 0.07% | 142 |
|
|
2014
Q4 | $159K | Buy |
+2,300
| New | +$155K | 0.07% | 138 |
|
Other funds holding LLY
Chicago Partners Investment Group's LLY Position: Q2 2026 in Review
Chicago Partners Investment Group reduced its Eli Lilly (LLY) stake by 17% in Q2 2026, selling an estimated $3.84M and leaving 18,216 shares worth $21.6M. The position accounts for 0.43% of the portfolio, ranked #50.
Chicago Partners Investment Group first reported a position in LLY in Q4 2014 and has held it in 47 quarters since. The position peaked at $22.8M in Q4 2025. 4,600 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Chicago Partners Investment Group held 18,216 shares of Eli Lilly worth $21.6M as of Q2 2026.
- Chicago Partners Investment Group sold 3,758 Eli Lilly shares in Q2 2026, an estimated $3.84M.
- Eli Lilly made up 0.43% of Chicago Partners Investment Group's portfolio in Q2 2026, its #50 holding.
- Chicago Partners Investment Group first reported a position in Eli Lilly in Q4 2014 and has held it in 47 quarters since.
- Chicago Partners Investment Group's Eli Lilly position peaked at $22.8M in Q4 2025.
- 4,600 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.